Comprehensive multi-factor analysis and exploration for the pathogenesis of non-ischemic cardiomyopathy and ischemic

Fengling Li1, Lin Cheng1, Lin Ma1

  • 1Department of Cardiology, Shan Xian Central Hospital, Shandong 274300, China.

Insights

This study identifies key genes and regulatory factors driving both non-ischemic and ischemic cardiomyopathy. Understanding these core pathogenic drivers improves insights into heart disease mechanisms.

Area of Science:

  • Genomics and Molecular Biology
  • Cardiovascular Research
  • Systems Biology

Background:

  • Cardiomyopathy encompasses diverse heart diseases impacting cardiac function.
  • While progress has been made, the precise molecular mechanisms of cardiomyopathy pathogenesis remain unclear.
  • Distinguishing between non-ischemic and ischemic cardiomyopathy is crucial for understanding disease drivers.

Purpose of the Study:

  • To modularize the pathogenesis of non-ischemic and ischemic cardiomyopathy.
  • To identify common core pathogenic driver genes shared between these cardiomyopathy types.
  • To uncover potential regulatory factors, including non-coding RNAs and transcription factors, involved in cardiomyopathy.

Main Methods:

  • Differential gene expression analysis on patient data.
  • Co-expression network analysis to identify gene modules.
  • Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis.
  • Hypergeometric tests to predict regulatory non-coding RNAs (ncRNAs) and transcription factors (TFs).

Main Results:

  • Identified 8 co-expression modules, highlighting HN1 and PRDX3 as key genes in cardiomyopathy pathogenesis.
  • Module genes are significantly involved in neutrophil-mediated immune responses and pathways like Vibrio cholerae infection.
  • Identified key regulatory ncRNAs (e.g., MALAT1, miR-133a-3p) and TFs (e.g., NFKB1, RELA).

Conclusions:

  • Decoded a co-expression network central to non-ischemic and ischemic cardiomyopathy.
  • Discovered core dysfunction modules and potential regulatory factors driving cardiomyopathy.
  • Enhanced understanding of the molecular pathogenesis of cardiomyopathy, aiding future therapeutic strategies.

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
347
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
231
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
244
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.5K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
270
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
297